Implementation of the NCI-60 Human Tumor Cell Line Panel to Screen 2260 Cancer Drug Combinations to Generate >3 Million Data Points Used to Populate a Large Matrix of Anti-Neoplastic Agent Combinations (ALMANAC) Database

SLAS Discovery- United States

doi 10.1177/2472555218812429

Full Text

Abstract

Available in

Date

Authors

Publisher

SAGE Publications

Related search

A Map of Mobile DNA Insertions in the NCI-60 Human Cancer Cell Panel

Mobile DNA
Molecular Biology
2016English

Validating the Extract, Transform, Load Process Used to Populate a Large Clinical Research Database

International Journal of Medical Informatics
Health Informatics
2016English

Testing Drug Combinations to Slow Aging

Pathobiology of Aging and Age-related Diseases
AgingGerontologyGeriatricsHistology
2017English

In-Silico Prediction of Synergistic Anti-Cancer Drug Combinations Using Multi-Omics Data

Scientific Reports
Multidisciplinary
2019English

Figure 4: New System Is Used to Test Other Drug Combinations (Exceptions).

English

Looking Beyond the Cancer Cell for Effective Drug Combinations

Genome Medicine
Molecular MedicineGeneticsMolecular Biology
2016English

Profiling SLCO and SLC22 Genes in the NCI-60 Cancer Cell Lines to Identify Drug Uptake Transporters

Molecular Cancer Therapeutics
Cancer ResearchOncology
2008English

Barrier to Resistance of Dolutegravir in Two-Drug Combinations

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2019English

Application of Fractional Factorial Designs to Study Drug Combinations

Statistics in Medicine
EpidemiologyStatisticsProbability
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy